Post by Napcooon Sep 24, 2025 7:15pm
20 Views
Post# 36726588
Ser 155 phase 2 funding
Ser 155 phase 2 fundingPositives so far (guessing)
1) CRO to be used, it should be more efficient
2) trial expected to be started soon
3) funding should be available soon before trial started, not a good time to be acquired, so might be notes or other loans, less than 10% interest
Negative(guessing)
1) nestle vowst sales not high enough, < 100 mln per year, so acquisition from nestle highly unlikely
2) mm might bury the calls and puts
3) trial with 248 patients expected to be enrolled half within 12 months from starting of the trial, means not as many patients potential for the future after FDA approved